ISRCTN80690743.
Study name | Project HASHTAG: testing a school‐based intervention to improve adolescent mental health in Nepal and South Africa |
Methods |
Study design: cluster‐RCT Country: Nepal and South Africa |
Participants | School‐going adolescents in South Africa (grade 8) and Nepal (grade 7‐9) Inclusion criteria: a. school‐going adolescents in South Africa (grade 8) and Nepal (grade 7‐9) Exclusion criteria: not specified Stated purpose: as this is a feasibility trial, we will evaluate the feasibility of the intervention and trial procedures. |
Interventions |
Intervention: HASHTAG HASHTAG is a multi‐level intervention for young people in grade 8 or equivalent that aims to promote positive mental health and prevent mental health conditions (specifically, depression and anxiety) and reduce risk behaviours. The HASHTAG intervention comprises two modules: 1) Thriving Environment in Schools (TES), a whole‐school intervention, and 2) Thriving Together (TT), a group‐based intervention delivered directly to young adolescents. TES is a school climate improvement strategy that seeks to modify adolescents’ social and emotional environment through a whole‐school approach to create a school culture of connectedness and supportive relationships. It will include 1) School Action Groups, 2) teacher‐focused workshops, and 3) mental health awareness raising activities. TT will be delivered to students in grade 8 in South Africa and grade 7‐9 in Nepal. It will include six 90‐minute weekly sessions focused on emotional regulation, stress management, problem‐solving, interpersonal skills and relationships, and assertiveness training. Control: Enhanced treatment as usual (eTAU: control arm schools will receive a shortened version of the student sessions after follow‐up interviews are complete). |
Outcomes |
Participants' outcomes of interest for this review
Economic outcomes Nil Time points: baseline, post‐intervention (immediately post‐intervention) |
Starting date | 18 July 2019 (recruitment start date: 1 March 2021) |
Contact information | Prof Mark Tomlinson, markt@sun.ac.za |
Notes |
Source of funding: Medical Research Council (UK) Prospective trial registration number: ISRCTN80690743 |